🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase III trial studies ibrutinib and rituximab to see how well they w...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-03-10
Trial ID
NCT02048813
This is a prospective multicenter phase 2 study designed with the purpose t...
Status
Recruiting
Location
Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College
Start Date
2019-05-15
Trial ID
NCT03980002
Treatments Being Tested
This research study is evaluating a new drug called ibrutinib in combinatio...
Status
Active Not Recruiting
Location
University of Miami Sylvester Comprehensive Cancer Center
Start Date
2014-10
Trial ID
NCT02251548
Treatments Being Tested
The purpose of this study is to establish the safety of orally administered...
Status
Completed
Location
Dana Farber Cancer Center
Start Date
2011-02
Trial ID
NCT01292135
Treatments Being Tested
The aim of this study is to evaluate if standard chemoimmunotherapy (FCR, B...
Status
Completed
Location
Medizinische Universitaet Wien
Start Date
2016-12-13
Trial ID
NCT02950051
Treatments Being Tested
The aim of this study is to test the potential benefit of an innovative com...
Status
Completed
Location
CH Annecy Genevois - Hématologie A3
Start Date
2019-09-27
Trial ID
NCT04010968
Treatments Being Tested